# Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder

> **NCT00277654** · PHASE3 · COMPLETED · sponsor: **Lindner Center of HOPE** · enrollment: 111 (actual)

## Conditions studied

- Bipolar Disorder
- Anxiety Disorder

## Interventions

- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT00277654
- **Lead sponsor:** Lindner Center of HOPE
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2011-12-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00277654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00277654, "Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00277654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*